Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E8MW
|
||||
Former ID |
DIB016466
|
||||
Drug Name |
D-1367
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Arthritis [ICD9: 710-719; ICD10:M00-M25] | Discontinued in Phase 1 | [1] | ||
Company |
UCB Celltech
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C12H25BO2
|
||||
Canonical SMILES |
B1(OC(C(O1)(C)C)(C)C)CCC(C)(C)C
|
||||
InChI |
1S/C12H25BO2/c1-10(2,3)8-9-13-14-11(4,5)12(6,7)15-13/h8-9H2,1-7H3
|
||||
InChIKey |
JAHKBUBFJVAEDA-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Cyclooxygenase | Target Info | Modulator | [2] | |
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005889) | ||||
REF 2 | US patent application no. 2007,0072,861, Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.